Zerad L, Gacem N, Gayda F, Day L, Sinigaglia K, Richard L
Cells. 2024; 13(23).
PMID: 39682701
PMC: 11639873.
DOI: 10.3390/cells13231952.
Moore S, Gawron J, Stevens M, Marziali L, Buys E, Milne G
Cell Mol Life Sci. 2024; 81(1):434.
PMID: 39400753
PMC: 11473742.
DOI: 10.1007/s00018-024-05463-1.
McCulloch M, Mehryab F, Rashnonejad A
Int J Mol Sci. 2024; 25(17).
PMID: 39273178
PMC: 11395143.
DOI: 10.3390/ijms25179227.
Prior R, Silva A, Vangansewinkel T, Idkowiak J, Tharkeshwar A, Hellings T
Brain. 2024; 147(9):3113-3130.
PMID: 38743588
PMC: 11370802.
DOI: 10.1093/brain/awae158.
Yan Y, Shetty M, Harding H, George G, Zyryanova A, Labbe K
Proc Natl Acad Sci U S A. 2024; 121(14):e2320013121.
PMID: 38547060
PMC: 10998612.
DOI: 10.1073/pnas.2320013121.
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B.
Touvier T, Veneri F, Claessens A, Ferri C, Mastrangelo R, Sorgiati N
bioRxiv. 2024; .
PMID: 38352425
PMC: 10862880.
DOI: 10.1101/2024.01.31.577760.
Knockout of PA200 improves proteasomal degradation and myelination in a proteotoxic neuropathy.
VerPlank J, Gawron J, Silvestri N, Wrabetz L, Feltri M
Life Sci Alliance. 2024; 7(4).
PMID: 38320810
PMC: 10847332.
DOI: 10.26508/lsa.202302349.
The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response.
Nait-Saidi R, Chartier A, Abgueguen E, Guedat P, Simonelig M
Open Biol. 2023; 13(4):230008.
PMID: 37042114
PMC: 10090878.
DOI: 10.1098/rsob.230008.
Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease.
Hertzog N, Jacob C
Neural Regen Res. 2023; 18(9):1931-1939.
PMID: 36926710
PMC: 10233759.
DOI: 10.4103/1673-5374.367834.
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism.
Veneri F, Prada V, Mastrangelo R, Ferri C, Nobbio L, Passalacqua M
Hum Mol Genet. 2022; 31(24):4255-4274.
PMID: 35908287
PMC: 9759335.
DOI: 10.1093/hmg/ddac170.
Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice.
Bai Y, Treins C, Volpi V, Scapin C, Ferri C, Mastrangelo R
Mol Neurobiol. 2022; 59(7):4159-4178.
PMID: 35501630
PMC: 9167212.
DOI: 10.1007/s12035-022-02838-y.
Mechanisms and Treatments in Demyelinating CMT.
Fridman V, Saporta M
Neurotherapeutics. 2021; 18(4):2236-2268.
PMID: 34750751
PMC: 8804145.
DOI: 10.1007/s13311-021-01145-z.
Pharmacological targeting of endoplasmic reticulum stress in disease.
Marciniak S, Chambers J, Ron D
Nat Rev Drug Discov. 2021; 21(2):115-140.
PMID: 34702991
DOI: 10.1038/s41573-021-00320-3.
Higher-order phosphatase-substrate contacts terminate the integrated stress response.
Yan Y, Harding H, Ron D
Nat Struct Mol Biol. 2021; 28(10):835-846.
PMID: 34625748
PMC: 8500838.
DOI: 10.1038/s41594-021-00666-7.
Animal Models as a Tool to Design Therapeutical Strategies for CMT-like Hereditary Neuropathies.
Bosco L, Falzone Y, Previtali S
Brain Sci. 2021; 11(9).
PMID: 34573256
PMC: 8465478.
DOI: 10.3390/brainsci11091237.
Activation of mTORC1 and c-Jun by Prohibitin1 loss in Schwann cells may link mitochondrial dysfunction to demyelination.
Della-Flora Nunes G, Wilson E, Hurley E, He B, OMalley B, Poitelon Y
Elife. 2021; 10.
PMID: 34519641
PMC: 8478418.
DOI: 10.7554/eLife.66278.
Raising cGMP restores proteasome function and myelination in mice with a proteotoxic neuropathy.
VerPlank J, Gawron J, Silvestri N, Feltri M, Wrabetz L, Goldberg A
Brain. 2021; 145(1):168-178.
PMID: 34382059
PMC: 9126006.
DOI: 10.1093/brain/awab249.
Wrestling and Wrapping: A Perspective on SUMO Proteins in Schwann Cells.
Fergani I, Frick L
Biomolecules. 2021; 11(7).
PMID: 34356679
PMC: 8301837.
DOI: 10.3390/biom11071055.
Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.
Stavrou M, Sargiannidou I, Georgiou E, Kagiava A, Kleopa K
Int J Mol Sci. 2021; 22(11).
PMID: 34205075
PMC: 8199910.
DOI: 10.3390/ijms22116048.
Calcineurin Activity Is Increased in Charcot-Marie-Tooth 1B Demyelinating Neuropathy.
Sidoli M, Reed C, Scapin C, Paez P, Cavener D, Kaufman R
J Neurosci. 2021; 41(20):4536-4548.
PMID: 33879538
PMC: 8152608.
DOI: 10.1523/JNEUROSCI.2384-20.2021.